Compare NTST & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTST | LMAT |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2020 | 2006 |
| Metric | NTST | LMAT |
|---|---|---|
| Price | $20.14 | $81.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | $22.02 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 1.2M | 360.3K |
| Earning Date | 04-20-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.28% | 0.93% |
| EPS Growth | ★ 150.00 | 30.57 |
| EPS | 0.12 | ★ 1.42 |
| Revenue | $195,006,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $19.03 | $14.21 |
| Revenue Next Year | $16.25 | $8.88 |
| P/E Ratio | $167.13 | ★ $56.99 |
| Revenue Growth | ★ 19.79 | 13.53 |
| 52 Week Low | $17.02 | $78.65 |
| 52 Week High | $22.47 | $118.01 |
| Indicator | NTST | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 34.47 | 31.91 |
| Support Level | $20.11 | N/A |
| Resistance Level | $21.01 | $89.00 |
| Average True Range (ATR) | 0.46 | 4.10 |
| MACD | -0.23 | -2.51 |
| Stochastic Oscillator | 14.18 | 8.01 |
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.